NasdaqCM - Delayed Quote USD

Sintx Technologies, Inc. (SINT)

1.5600 -0.0600 (-3.70%)

At close: November 6 at 4:00:00 PM EST

SINTX Technologies Inc (SINT) (Q3 2026) Earnings Call Highlights: Record Revenue Surge and ...

GuruFocus.com 2d ago

SINT
-3.70%
SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization

GlobeNewswire 2d ago

SINT
-3.70%
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast

GlobeNewswire 17d ago

SINT
-3.70%
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock

Zacks 30d ago

SINT
-3.70%
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance

GlobeNewswire 1mo ago

SINT
-3.70%
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire 1mo ago

SINT
-3.70%
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade

Zacks 2mo ago

SINT
-3.70%
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

GlobeNewswire 2mo ago

SINT
-3.70%
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...

GuruFocus.com 2mo ago

SINT
-3.70%
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

GlobeNewswire 2mo ago

SINT
-3.70%
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

GlobeNewswire 3mo ago

SINT
-3.70%
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

GlobeNewswire 4mo ago

SINT
-3.70%

U.S. markets closed

Sintx Technologies, Inc. (SINT)

SINTX Technologies Inc (SINT) (Q3 2026) Earnings Call Highlights: Record Revenue Surge and ...

SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization

SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast

What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock

SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade

SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...

SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders